Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Ascendis Pharma A (ASND) over the last 14 years, with Q3 2025 value amounting to $3764.4.

  • Ascendis Pharma A's Shares Outstanding (Weighted Average) fell 4219.75% to $3764.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $3764.4, marking a year-over-year decrease of 4219.75%. This contributed to the annual value of $62.7 million for FY2024, which is 346.22% up from last year.
  • Ascendis Pharma A's Shares Outstanding (Weighted Average) amounted to $3764.4 in Q3 2025, which was down 4219.75% from $2513.0 recorded in Q2 2025.
  • Ascendis Pharma A's 5-year Shares Outstanding (Weighted Average) high stood at $62.7 million for Q4 2021, and its period low was $1411.3 during Q1 2021.
  • For the 5-year period, Ascendis Pharma A's Shares Outstanding (Weighted Average) averaged around $12.8 million, with its median value being $4508.1 (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 7575.09% in 2022, then crashed by 4457.17% in 2025.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Shares Outstanding (Weighted Average) stood at $62.7 million in 2021, then decreased by 8.7% to $57.2 million in 2022, then increased by 5.86% to $60.6 million in 2023, then rose by 2.15% to $61.9 million in 2024, then plummeted by 99.99% to $3764.4 in 2025.
  • Its Shares Outstanding (Weighted Average) was $3764.4 in Q3 2025, compared to $2513.0 in Q2 2025 and $1662.0 in Q1 2025.